Catherine Coste - 10 Jun 2022 Form 4 Insider Report for MINERVA SURGICAL INC

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 10 Jun 2022
Net transaction value: +$119,999
SEC form: 4
Accepted by SEC: 14 Jun 2022, 13:05:15 UTC
Prior SEC filing: 10 Dec 2021
Next SEC filing: 30 Jan 2023
Source filing: View source filing
Reporting owner signature: Lenka Schvaigerova, Attorney-in-fact for Catherine Coste

Key filing fact

Catherine Coste filed Form 4 for MINERVA SURGICAL INC on 14 Jun 2022.

Key facts

This page summarizes Catherine Coste's Form 4 filing for MINERVA SURGICAL INC.
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 Jun 2022, 13:05.

Change

Previous filing in this sequence was filed on 10 Dec 2021.
Current net transaction value: +$119,999.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

UTRS transaction

Common Stock

Award

Transaction value: $119,999
Shares: +49,792
Change %: +62%
Price: $2.41^*
Shares after: 129,579
Date: 10 Jun 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. Each RSU award will vest in four equal quarterly installments on the quarterly anniversary of the grant date, subject to the Reporting Person continuing as a service provider through each such date.

Footnote F2

79,787 shares were acquired pursuant to the exercise of an early-exercise option and remain subject to a right of repurchase by the Company, which shall lapse with respect to one-fourth of the shares on February 1, 2022 and with respect to one thirty-sixth of the remaining shares each month thereafter.